404 related articles for article (PubMed ID: 19335746)
1. The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies.
Davie NJ; Schermuly RT; Weissmann N; Grimminger F; Ghofrani HA
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():38-49. PubMed ID: 19335746
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?
Jacobs A; Preston IR; Gomberg-Maitland M
Curr Med Res Opin; 2006 Dec; 22(12):2567-74. PubMed ID: 17166339
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.
Abman SH
Annu Rev Med; 2009; 60():13-23. PubMed ID: 18764741
[TBL] [Abstract][Full Text] [Related]
4. [Endothelin receptor antagonists in pulmonary arterial hypertension].
Tokgöz HC; Can MM; Kaymaz C
Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():9-15. PubMed ID: 20819750
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor antagonists in pulmonary arterial hypertension.
Channick RN; Sitbon O; Barst RJ; Manes A; Rubin LJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):62S-67S. PubMed ID: 15194180
[TBL] [Abstract][Full Text] [Related]
6. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.
Neuhofer W; Pittrow D
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():50-67. PubMed ID: 19335747
[TBL] [Abstract][Full Text] [Related]
7. Endothelin receptor antagonists in preclinical models of pulmonary hypertension.
Pullamsetti SS; Schermuly RT
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():3-13. PubMed ID: 19335741
[TBL] [Abstract][Full Text] [Related]
8. Endothelin receptor antagonists.
Motte S; McEntee K; Naeije R
Pharmacol Ther; 2006 Jun; 110(3):386-414. PubMed ID: 16219361
[TBL] [Abstract][Full Text] [Related]
9. Endothelin receptor blockade in the management of pulmonary arterial hypertension: selective and dual antagonism.
Trow TK; Taichman DB
Respir Med; 2009 Jul; 103(7):951-62. PubMed ID: 19304472
[TBL] [Abstract][Full Text] [Related]
10. Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma.
Shiwen X; Leask A; Abraham DJ; Fonseca C
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():19-26. PubMed ID: 19335743
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor antagonists for pulmonary arterial hypertension: an overview.
Raja SG
Cardiovasc Ther; 2010 Oct; 28(5):e65-71. PubMed ID: 20406243
[TBL] [Abstract][Full Text] [Related]
12. [Update: Current clinical developments in pulmonary hypertension].
Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
[TBL] [Abstract][Full Text] [Related]
13. Endothelin receptor antagonists -- their role in pulmonary medicine.
Boniface S; Reynaud-Gaubert M
Rev Mal Respir; 2011 Oct; 28(8):e94-e107. PubMed ID: 22099418
[TBL] [Abstract][Full Text] [Related]
14. Treatments for pulmonary arterial hypertension.
Liu C; Liu K; Ji Z; Liu G
Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344
[TBL] [Abstract][Full Text] [Related]
15. Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.
Opitz CF; Ewert R
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():1-9. PubMed ID: 16919004
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials.
Aubert JD; Juillerat-Jeanneret L
Expert Opin Ther Targets; 2009 Sep; 13(9):1069-84. PubMed ID: 19659448
[TBL] [Abstract][Full Text] [Related]
17. Current status of endothelin blockade for the treatment of cardiovascular and pulmonary vascular disease.
Krum H; Liew D
Curr Opin Investig Drugs; 2003 Mar; 4(3):298-302. PubMed ID: 12744222
[TBL] [Abstract][Full Text] [Related]
18. Macitentan, a tissue-targeting endothelin receptor antagonist for the potential oral treatment of pulmonary arterial hypertension and idiopathic pulmonary fibrosis.
Raja SG
Curr Opin Investig Drugs; 2010 Sep; 11(9):1066-73. PubMed ID: 20730702
[TBL] [Abstract][Full Text] [Related]
19. The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension.
Shao D; Park JE; Wort SJ
Pharmacol Res; 2011 Jun; 63(6):504-11. PubMed ID: 21419223
[TBL] [Abstract][Full Text] [Related]
20. Bleeding events in pulmonary arterial hypertension.
Opitz CF; Kirch W; Mueller EA; Pittrow D
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():68-73. PubMed ID: 19335748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
